Article By:
Tobias Carlisle
Friday, February 13, 2026 12:00 PM EST
For long-term investors, TMO represents a durable compounder benefiting from structural demand in healthcare and biotechnology.
In this article: TMO
Read
Article By:
ING Economics
Friday, February 13, 2026 11:00 AM EST
Japan will release key growth data next week, including GDP and exports.
In this article: EWJ
Read
Article By:
Brandon Green
Friday, February 13, 2026 10:00 AM EST
Inflation is always in the background for those of us who follow metals. But lately, with the dollar weakening and both stocks and hard assets rising together, it feels worth revisiting a simple question.
In this article: SLV
Read
Article By:
Brian Romanchuk
Friday, February 13, 2026 9:40 AM EST
The Payrolls Employment Report in the United States released earlier this week was stronger than expected.
Read
Article By:
Stefan Gleason
Friday, February 13, 2026 9:30 AM EST
The Federal Reserve put interest rate cuts on pause at the January meeting. The central bankers cited expanding economic activity and a stable labor market as reasons for the pause.
Read
Article By:
Tyler Durden
Friday, February 13, 2026 9:10 AM EST
Headline consumer price inflation came in cooler than expected in January (+0.2% MoM vs +0.3% expected).
Read
The market got off to a strong start in 2026, with investors chasing industrials, materials, and commodity-related stocks as the reflation narrative gained traction.
We are starting to see the beginnings of deglobalization: Countries are increasingly at odds with each other. There is wider disparity among political parties.
A breakout failure, hawkish Warsh surprise, weak seasonality, and High Trend Fragility suggest odds favor a sentiment washout is on the table.
IBIT is very large, extremely liquid, and down substantially in 2026. I bought the dip and sold profitably. I explain why I have my eyes on IBIT.
Coya Therapeutics is advancing a promising ALS treatment with financial support from partner Dr. Reddy's and investors like Greenlight Capital.
Pure‑play cybersecurity software stocks are down YTD because the market narrative has shifted against them, even as fundamentals remain intact. The YTD drawdown is a valuation and positioning story, not a fundamentals story.
According to data from Hedge Fund Research, hedge funds recorded their strongest annual performance in more than a decade, with an average 2025 return of 12.6% across all strategies.
